歯科用麻酔市場 - 世界の産業規模、シェア、動向、機会、予測、タイプ別、投与経路別、エンドユーザー別、地域別、競合別、2020～2030年

歯科用麻酔の世界市場規模は2024年に21億1,000万米ドルとなり、予測期間中のCAGRは5.68%で2030年には29億4,000万米ドルに達すると予測されています。

歯科用麻酔の世界市場は大きな成長を遂げており、その原動力となっているのは、低コストの無痛治療に対する需要の高まりと、人々の美意識の高まりが相まって、世界のさまざまな地域で歯科用麻酔の需要が大幅に増加していることです。さらに、さまざまな種類の虫歯、損失、損傷を受けやすい世界中の高齢者人口の増加は、さまざまな歯科用麻酔の需要をさらに増加させ、2028年までの市場成長を促進すると予想されています。また、口腔の健康や衛生に関する意識の高まりや、世界中で歯の問題に対する支出が増加していることも、予測期間中の歯科用麻酔市場をさらに後押しすると期待されています。

市場促進要因

高齢化と歯科治療需要の増加

主な市場課題

熟練した麻酔専門家の不足

主な市場動向

無針麻酔とコンピュータ制御麻酔デリバリーの出現

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の歯科用麻酔市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（局所麻酔、全身麻酔、鎮静）
  • 投与経路別（口腔内、口腔外）
  • エンドユーザー別（歯科医院、歯科技工所、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ
  • タイプ別
  • 投与経路別
  • エンドユーザー別
  • 地域別

第6章 北米の歯科用麻酔市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の歯科用麻酔市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の歯科用麻酔市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の歯科用麻酔市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの歯科用麻酔市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第14章 SWOT分析：世界の歯科用麻酔市場

第15章 競合情勢

• Septodont, Inc.
• Henry Schein, Inc.
• Dentsply Sirona, Inc.
• AstraZeneca, Plc.
• Abbott Laboratories, Inc.
• Gilead Sciences, Inc.
• Hospira, Inc.
• Hikma Pharmaceuticals, Plc.
• 3M Company
• Aspen Group

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Dental Anesthesia Market was valued at USD 2.11 billion in 2024 and is expected to reach USD 2.94 billion by 2030 with a CAGR of 5.68% during the forecast period. The global market for Dental Anesthesia is experiencing significant growth, driven by the growing demand for painless treatment with low cost coupled with increasing aesthetic consciousness among the population has significantly increased the demand for dental anesthesia across different parts of the globe. Additionally, the rowing geriatric population across the globe which is susceptible to different kinds of tooth decay, loss, and damage is further expected to increase the demand for different dental anesthesia, thereby fuelling the market growth through 2028. Besides, growing awareness pertaining to oral health & hygiene along with increasing expenditure on dental problems across the globe is further expected to support the dental anesthesia market during the forecast period.

Key Market Drivers

Aging Population & Rising Dental Treatment Demand

A primary driver of dental anesthesia adoption is the growing global aging population, which increases the demand for both routine and complex dental procedures. According to the World Health Organization (WHO), the number of individuals aged 60 or above is projected to reach 2.1 billion by 2050, nearly double the number in 2015. This demographic shift brings a higher incidence of chronic conditions, such as gum disease, tooth loss, and root canal infections requiring effective anesthetic techniques to manage procedural complexity and patient comfort.

In many communities, elderly patients account for a growing share of dental visits, often involving multiple extractions, implant placements, and periodontal surgeries. Effective anesthesia is essential not only to ensure procedural precision but also to support pain management in individuals who may have comorbidities or sensitivities. Public healthcare systems-like Medicare in the U.S.-regularly reimburse anesthesia services for complex dental treatments, encouraging widespread adoption.

Furthermore, the global rise in oral health awareness (where nearly 3.5 billion people suffer from untreated cavities according to WHO) strengthens patient demand for dental care. As dental clinics expand worldwide, anesthesia becomes a core standard of care, especially for invasive or anxiety-inducing treatments. Essentially, the convergence of an aging population, greater dental need, and systemic healthcare support significantly fuels growth in dental anesthesia usage.

Key Market Challenges

Shortage of Skilled Anesthesia Professionals

A major challenge lies in the limited availability of trained dental anesthesiologists and sedation-certified clinicians. According to the American Society of Anesthesiologists (ASA) and Association of American Medical Colleges (AAMC), the U.S. faces a projected shortage of 12,500-15,000 anesthesiologists by 2030, with a significant portion required for procedural sedation. In dentistry, stringent sedation protocols and safety regulations necessitate specialized training requirement many smaller clinics and rural providers struggle to meet.

This shortage impacts service availability, extends wait times for sedation-requiring procedures, and limits anesthesia innovation adoption. The challenge is even more pronounced in developing regions, where healthcare worker density remains low, and specialized training is limited. Addressing this requires expanded training programs, cross-certification models, and task-sharing-many of which are currently under-supported.

Key Market Trends

Emergence of Needle-Free & Computer-Controlled Anesthetic Delivery

A significant trend advancing the dental anesthesia market is the development and adoption of needle-free and computerized anesthetic delivery systems. These technologies aim to improve accuracy, reduce injection pain, and enhance patient comfort. Needle-free jet injectors use high-pressure streams to deliver anesthesia through the skin, bypassing needles altogether-an approach especially valuable in pediatric dentistry. The 2024 clinical study found these systems to be as effective as traditional needle approaches and greatly reduced anxiety in children. Computer-Controlled Local Anesthetic Delivery (C-CLAD) systems regulate flow, pressure, and rate, allowing dentists to optimize dosing with minimal discomfort. These systems also support advanced protocols-such as palatal injection numbing for adult procedures-and align with precision dosing requirements in medically complex or elderly patients.

Government-backed organizations, including the FDA, actively evaluate these devices for safety and efficacy, contributing to broader clinical adoption. This trend towards minimally invasive, patient-friendly technology significantly enhances clinical standards and drives innovation in dental anesthesia.

Key Market Players

• Septodont, Inc.
• Henry Schein, Inc.
• Dentsply Sirona, Inc.
• AstraZeneca, Plc.
• Abbott Laboratories, Inc.
• Gilead Sciences, Inc.
• Hospira, Inc.
• Hikma Pharmaceuticals, Plc.
• 3M Company
• Aspen Group

Report Scope:

In this report, the Global Dental Anesthesia Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dental Anesthesia Market, By Type:

• Local
• General
• Sedation

Dental Anesthesia Market, By Route of Administration:

• Intra-Oral
• Extra-Oral

Dental Anesthesia Market, By End User:

• Dental Hospitals
• Dental Laboratories
• Others

Dental Anesthesia Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Dental Anesthesia Market.

Available Customizations:

Global Dental Anesthesia Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dental Anesthesia Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Local, General, Sedation)
  • 5.2.2. By Route of Administration (Intra-Oral, Extra-Oral)
  • 5.2.3. By End User (Dental Hospitals, Dental Laboratories, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Route of Administration
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Dental Anesthesia Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Route of Administration
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dental Anesthesia Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Route of Administration
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Dental Anesthesia Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Route of Administration
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Dental Anesthesia Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Route of Administration
      • 6.3.3.2.3. By End User

7. Europe Dental Anesthesia Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Route of Administration
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Dental Anesthesia Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Route of Administration
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Dental Anesthesia Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Route of Administration
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Dental Anesthesia Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Route of Administration
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Dental Anesthesia Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Route of Administration
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Dental Anesthesia Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Route of Administration
      • 7.3.5.2.3. By End User

8. Asia-Pacific Dental Anesthesia Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Route of Administration
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Dental Anesthesia Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Route of Administration
      • 8.3.1.2.3. By End User
  • 8.3.2. India Dental Anesthesia Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Route of Administration
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Dental Anesthesia Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Route of Administration
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Dental Anesthesia Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Route of Administration
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Dental Anesthesia Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Route of Administration
      • 8.3.5.2.3. By End User

9. South America Dental Anesthesia Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Route of Administration
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Dental Anesthesia Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Route of Administration
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Dental Anesthesia Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Route of Administration
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Dental Anesthesia Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Route of Administration
      • 9.3.3.2.3. By End User

10. Middle East and Africa Dental Anesthesia Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Route of Administration
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Dental Anesthesia Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Route of Administration
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Dental Anesthesia Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Route of Administration
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Dental Anesthesia Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Route of Administration
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. SWOT Analysis: Global Dental Anesthesia Market

15. Competitive Landscape

• 15.1. Septodont, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Henry Schein, Inc.
• 15.3. Dentsply Sirona, Inc.
• 15.4. AstraZeneca, Plc.
• 15.5. Abbott Laboratories, Inc.
• 15.6. Gilead Sciences, Inc.
• 15.7. Hospira, Inc.
• 15.8. Hikma Pharmaceuticals, Plc.
• 15.9. 3M Company
• 15.10. Aspen Group

16. Strategic Recommendations

17. About Us & Disclaimer